Stockscreener 앱 받기
3.21
1.23%
-0.04
전일 마감가:
$3.25
열려 있는:
$3.295
하루 거래량:
15,811
Relative Volume:
0.75
시가총액:
$4.31M
수익:
순이익/손실:
$-11.00M
주가수익비율:
-8.1143
EPS:
-0.3956
순현금흐름:
$-11.99M
1주 성능:
-13.01%
1개월 성능:
-8.55%
6개월 성능:
-65.41%
1년 성능:
-94.69%
1일 변동 폭
$3.21
$3.3642
1주일 범위
$3.21
$3.82
52주 변동 폭
$3.21
$141.50
Liminatus Pharma Inc Stock (LIMN) Company Profile
명칭
Liminatus Pharma Inc
전화
213-273-5453
주소
12611 HIDDENCREEK WAY, CERRITOS
Compare LIMN vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
3.21 | 4.31M | 0 | -11.00M | -11.99M | -0.3956 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Liminatus Pharma Inc 주식(LIMN)의 최신 뉴스
SkinHealth Systems to Implement 1-for-20 Reverse Stock Split - Yahoo Finance
Form 8K Liminatus Pharma Inc Class A For: 29 September By Investing.com - Investing.com South Africa
Form 8K Liminatus Pharma Inc Class A For: 29 September By Investing.com - Investing.com Nigeria
Form 8K Liminatus Pharma Inc Class A For: 29 September By Investing.com - Investing.com India
Liminatus Pharma, Inc. (LIMN) Stock Price, Chart, News & Analysis - Securities.io
Enterprise value to EBITDA forward of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Price to sales forward of Liminatus Pharma, Inc. – BOATS:LIMNW - TradingView
Liminatus Pharma selects Synex to advance CAR-T trial - Clinical Trials Arena
Liminatus Pharma selects Synex to advance CAR-T trial - Yahoo
Liminatus engages Synex for IBC101 CAR-T clinical development - Investing.com
Liminatus Pharma Engages Synex Consulting to Support Clinical Development of IBC101 CAR-T Therapy in South Korea - Quiver Quantitative
Liminatus engages Synex for IBC101 CAR-T clinical development By Investing.com - Investing.com UK
Korea’s Ministry of Food and Drug Safety authorizes Liminatus study - Stock Titan
Longeveron Announces 1-for-10 Reverse Stock Split - Yahoo Finance
Nasdaq Orders Immediate Suspension of Flash Sports & Media Stock - minichart.com.sg
Press Releases about Liminatus Pharma, Inc.Class A Common Stock (Nasdaq:LIMN) - FinancialContent
17,272,739 Common Stock of Liminatus Pharma, Inc. are subject to a Lock-Up Agreement Ending on 19-AUG-2026. - marketscreener.com
Liminatus Pharma to implement 1-for-50 reverse stock split - Investing.com
Liminatus Pharma Enacts Reverse Split to Maintain Listing - TipRanks
Liminatus Pharma announces 1-for-50 reverse stock split - TipRanks
Liminatus Pharma to implement 1-for-50 reverse stock split By Investing.com - Investing.com India
Liminatus Pharma Announced Transfer or Voluntary Withdrawal of Listing - TradingView
Liminatus Pharma to implement 1-for-50 reverse stock split By Investing.com - Investing.com UK
Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock - The Manila Times
Liminatus Pharma, Inc. Announces Reverse Stock Split of Its Common Stock - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
Liminatus (NASDAQ: LIMN) turns to 1-for-50 split as Nasdaq listing hangs on $1 bid - Stock Titan
Liminatus Pharma (LIMN) Stock Analysis Report | Financials & Insights - Benzinga France
Liminatus Pharma Warrants (LIMNW) Tumble 13.79% to $0.05 as Key Level Comes Into FocusScalping Stock Signals - vinanet.vn
Liminatus Pharma Warrants (LIMNW) Tumble 13.79% to $0.05 as Key Level Comes Into FocusChannel Projection - dars.gov.et
Liminatus Pharma (LIMN) Slides 6.6% to $0.14, Testing Critical $0.13 SupportLow Vol ETF - vinanet.vn
Liminatus Pharma, Inc. Q2 2026: Net income $(1.41)M, EPS $(0.03) — 10-Q Summary - TradingView
Liminatus Pharma (LIMN) logs $2.5M loss and fights Nasdaq listing threats - Stock Titan
Liminatus Pharma (LIMN) Slides 6.6% to $0.14, Testing Critical $0.13 SupportPullback Trade - dars.gov.et
Liminatus Pharma (LIMN) Stock Jumps Over 50% on a Listing Update - TipRanks
These stocks are the most active in today's session - ChartMill
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Liminatus Pharma moves to Nasdaq Capital Market By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Liminatus Pharma moves to Nasdaq Capital Market By Investing.com - Investing.com Canada
Liminatus Pharma moves to Nasdaq Capital Market By Investing.com - Investing.com South Africa
Liminatus Pharma moves to Nasdaq Capital Market - Investing.com
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement - The Manila Times
Liminatus Pharma moves to Nasdaq Capital Market By Investing.com - Investing.com Australia
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Bid Price Compliance - Quiver Quantitative
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance ... - Herald and News
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance With Minimum Bid Price Requirement - Moomoo
These stocks are moving in today's pre-market session - ChartMill
$Liminatus Pharma (LIMN.US)$ - moomoo.com
Liminatus Pharma Warrants (LIMNW) Jump 34% to $0.07 as Traders Eye Key Inflection PointFear Greed Extreme - vinanet.vn
Liminatus Pharma Inc (LIMN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.35%
자본화:
|
볼륨(24시간):